دورية أكاديمية
أعرض في EDS

Opioid Prescribing Patterns for Ulcerative Keratitis.

التفاصيل البيبلوغرافية
العنوان: Opioid Prescribing Patterns for Ulcerative Keratitis.
المؤلفون: Thibodeau AR; Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI; and., Niziol LM; Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI; and., Tannen BL; Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI; and., Ballouz D; Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI; and., Woodward MA; Department of Ophthalmology and Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI; and.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI.
المصدر: Cornea [Cornea] 2022 Apr 01; Vol. 41 (4), pp. 484-490.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8216186 Publication Model: Print Cited Medium: Internet ISSN: 1536-4798 (Electronic) Linking ISSN: 02773740 NLM ISO Abbreviation: Cornea Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: New York, N.Y. : Masson Pub. USA, c1982-
مواضيع طبية MeSH: Analgesics, Opioid/*therapeutic use , Corneal Ulcer/*drug therapy , Drug Prescriptions/*statistics & numerical data , Eye Pain/*drug therapy , Practice Patterns, Physicians'/*statistics & numerical data, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Pain Management/methods ; Retrospective Studies
مستخلص: Purpose: The purpose of this study was to characterize rates of opioid prescription for different ulcerative keratitis types.
Methods: This cohort study included patients diagnosed with ulcerative keratitis according to the University of Michigan electronic health record data between September 1, 2014 and December 22, 2020. Ulcerative keratitis was categorized by etiologic type (bacterial, fungal, viral, acanthamoeba, inflammatory, polymicrobial, or unspecified) using rule-based data classification that accounted for billing diagnosis code, antimicrobial or antiinflammatory medications prescribed, laboratory results, and manual chart review. Opioid prescriptions were converted to morphine milligram equivalent and summed over 90 days from diagnosis. Opioid prescription rate and amount were compared between ulcerative keratitis types.
Results: Of 3322 patients with ulcerative keratitis, 173 (5.2%) were prescribed at least 1 opioid for pain management within 90 days of diagnosis. More patients with acanthamoeba (32.4%), fungal (21.1%), and polymicrobial (25.0%) keratitis were treated with opioids compared with bacterial (6.7%), unspecified (2.9%), or viral (1.8%) keratitis (all Bonferroni adjusted P < 0.05). For the 173 patients who were prescribed opioids, a total of 353 prescriptions were given within 90 days of diagnosis, with half given within the first week after diagnosis. The quantity of opioid prescribed within 90 days from diagnosis was not significantly different between ulcerative keratitis types (P = 0.6559). Morphine milligram equivalent units prescribed ranged from 97.5 for acanthamoeba keratitis to 112.5 for fungal keratitis.
Conclusions: The type of ulcerative keratitis may influence the opioid prescription rate. Providers can better serve patients needing opioids for pain management through improved characterization of pain and development of more tailored pain management regimens.
Competing Interests: The authors have no conflicts of interest to disclose.
(Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
References: Pepose JS, Wilhelmus KR. Divergent approaches to the management of corneal ulcers. Am J Ophthalmol. 1992;114:630–632.
Byrd LB, Martin N. Corneal Ulcer. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2021.
Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214–221.
Sharma S. Keratitis. Biosci Rep. 2001;21:419–444.
Beuerman RW, Tanelian DL. Corneal pain evoked by thermal stimulation. Pain. 1979;7:1–14.
Goyal S, Hamrah P. Understanding neuropathic corneal pain: gaps and current therapeutic approaches. Semin Ophthalmol. 2016;31:59–70.
Müller LJ, Marfurt CF, Kruse F, et al. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76:521–542.
Yagci A, Bozkurt B, Egrilmez S, et al. Topical anesthetic abuse keratopathy: a commonly overlooked health care problem. Cornea. 2011;30:571–575.
Lee MD, Driver TH, Seitzman GD. Cornea specialists do not recommend routine usage of topical anesthetics for corneal abrasions. Ann Emerg Med. 2019;74:463–466.
Varga JH, Rubinfeld RS, Wolf TC, et al. Topical anesthetic abuse ring keratitis: report of four cases. Cornea. 1997;16:424–429.
Erdem E, Undar IH, Esen E, et al. Topical anesthetic eye drops abuse: are we aware of the danger? Cutan Ocul Toxicol. 2013;32:189–193.
Rosenwasser GO. Complications of topical ocular anesthetics. Int Ophthalmol Clin. 1989;29:153–158.
Pharmakakis NM, Katsimpris JM, Melachrinou MP, et al. Corneal complications following abuse of topical anesthetics. Eur J Ophthalmol. 2002;12:373–378.
Rocha G, Brunette I, Le François M. Severe toxic keratopathy secondary to topical anesthetic abuse. Can J Ophthalmol. 1995;30:198–202.
Soelberg CD, Brown RE Jr, Du Vivier D, et al. The US opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125:1675–1681.
Ung C, Yonekawa Y, Waljee JF, et al. Persistent opioid use after ophthalmic surgery in opioid-naive patients and associated risk factors. Ophthalmology. 2021;128:1266–1273.
Southren DL, Moser S, Abu-Amara H, et al. Opioid fills for lumbar facet radiofrequency ablation associated with new persistent opioid use. Anesthesiology. 2020;132:1165–1174.
Bennett KG, Kelley BP, Vick AD, et al. Persistent opioid use and high-risk prescribing in body contouring patients. Plast Reconstr Surg. 2019;143:87–96.
Habermann EB. Are opioids overprescribed following elective surgery? Adv Surg. 2018;52:247–256.
Hah JM, Bateman BT, Ratliff J, et al. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg. 2017;125:1733–1740.
Clarke H, Soneji N, Ko DT, et al. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:g1251.
Lawal OD, Gold J, Murthy A, et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open. 2020;3:e207367.
Harbaugh CM, Nalliah RP, Hu HM, et al. Persistent opioid use after wisdom tooth extraction. JAMA. 2018;320:504–506.
Zaveri S, Nobel TB, Khetan P, et al. Risk of chronic opioid use in opioid-naïve and non-naive patients after ambulatory surgery. J Gastrointest Surg. 2020;24:688–694.
Shah AS, Blackwell RH, Kuo PC, et al. Rates and risk factors for opioid dependence and overdose after urological surgery. J Urol. 2017;198:1130–1136.
Crystal DT, Blankensteijn LL, Ibrahim AMS, et al. Quantifying the crisis: opioid-related adverse events in outpatient Ambulatory plastic surgery. Plast Reconstr Surg. 2020;145:687–695.
Levy N, Quinlan J, El-Boghdadly K, et al. An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patients. Anaesthesia. 2021;76:520–536.
Kolomeyer AM, Yu Y, VanderBeek BL. Association of opioids with incisional ocular surgery. JAMA Ophthalmol. 2019;137:1283–1291.
Charlson ES, Feng PW, Bui A, et al. Opioid prescribing patterns among American society of ophthalmic plastic and reconstructive surgery members in the Medicare Part D Database. Ophthalmic Plast Reconstr Surg. 2019;35:360–364.
DataDirect. A self-serve tool for data retrieval; University of Michigan; 2015. Available at: https://datadirect.med.umich.edu/ . Accessed December 22, 2020.
CDC compilation of benzodiazepines, muscle relaxants, stimulants, zolpidem, and opioid analgesics with oral morphine milligram equivalent conversion factors. Available at: https://www.cdc.gov/drugoverdose/resources/data.html . Accessed May 1, 2021.
Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Med. 2010;11:1859–1871.
Bertakis KD, Azari R, Callahan EJ. Patient pain in primary care: factors that influence physician diagnosis. Ann Fam Med. 2004;2:224–230.
Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA. 2000;284:428–429.
Silvoniemi M, Vasankari T, Vahlberg T, et al. Physicians' self-assessment of cancer pain treatment skills: more training required. Support Care Cancer. 2012;20:2747–2753.
Garcia J, Ohanisian L, Sidley A, et al. Resident knowledge and perception of pain management. Cureus. 2019;11:e6107.
Pizzo PA, Clark NM. Alleviating suffering 101--pain relief in the United States. N Engl J Med. 2012;366:197–199.
Chang SHDU, Gupta PK, Hovanesian JA, et al. Consider patient perception of pain when planning cataract procedures. Available at: https://www.healio.com/news/ophthalmology/20171102/consider-patient-perception-of-pain-when-planning-cataract-procedures . Accessed May 1, 2021.
Jiang L, Zhang K, He W, et al. Perceived pain during cataract surgery with topical anesthesia: a comparison between first-eye and second-eye surgery. J Ophthalmol. 2015;2015:383456.
Chynn EW, Lopez MA, Pavan-Langston D, et al. Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology. 1995;102:1369–1373.
de Lacerda AG, Lira M. Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology. Ophthalmic Physiol Opt. 2021;41:116–135.
Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148:487–499.e482.
Maycock NJ, Jayaswal R. Update on acanthamoeba keratitis: diagnosis, treatment, and outcomes. Cornea. 2016;35:713–720.
Sun X, Zhang Y, Li R, et al. Acanthamoeba keratitis: clinical characteristics and management. Ophthalmology. 2006;113:412–416.
Radford CF, Lehmann OJ, Dart JK. Acanthamoeba keratitis: multicentre survey in England 1992-6. National acanthamoeba keratitis study group. Br J Ophthalmol. 1998;82:1387–1392.
Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15:321–327.
Bunya VY, Hammersmith KM, Rapuano CJ, et al. Topical and oral voriconazole in the treatment of fungal keratitis. Am J Ophthalmol. 2007;143:151–153.
Bonini S, Rama P, Olzi D, et al. Neurotrophic keratitis. Eye (Lond). 2003;17:989–995.
Davis EA, Dohlman CH. Neurotrophic keratitis. Int Ophthalmol Clin. 2001;41:1–11.
Liesegang TJ. Corneal complications from herpes zoster ophthalmicus. Ophthalmology. 1985;92:316–324.
Woodward MA, Zhang Y, Tannen B, et al. Association of limiting opioid prescriptions with use of opioids after corneal surgery. JAMA Ophthalmol. 2019;138:76–80.
Xie Y, Joseph AW, Rudy SF, et al. Change in postoperative opioid prescribing patterns for oculoplastic and orbital procedures associated with state opioid legislation. JAMA Ophthalmol. 2021;139:157–162.
Starr MR, Patel SV, Bartley GB, et al. Impact of standardized prescribing guidelines on postoperative opioid prescriptions after ophthalmic surgery. Ophthalmology. 2020;127:1454–1459.
Patel S, Sternberg P Jr. Association between opioid prescribing patterns and abuse in ophthalmology. JAMA Ophthalmol. 2017;135:1216–1220.
Chalmers RL, Wagner H, Mitchell GL, et al. Age and other risk factors for corneal infiltrative and inflammatory events in young soft contact lens wearers from the Contact Lens Assessment in Youth (CLAY) study. Invest Ophthalmol Vis Sci. 2011;52:6690–6696.
Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113:109–116.
Bennett L, Y Hsu H, Tai S, et al. Contact lens versus non-contact lens-related corneal ulcers at an academic center. Eye Contact Lens. 2019;45:301–305.
معلومات مُعتمدة: R01 EY031033 United States EY NEI NIH HHS
المشرفين على المادة: 0 (Analgesics, Opioid)
تواريخ الأحداث: Date Created: 20211008 Date Completed: 20220311 Latest Revision: 20230402
رمز التحديث: 20230403
مُعرف محوري في PubMed: PMC8897229
DOI: 10.1097/ICO.0000000000002893
PMID: 34620771
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-4798
DOI:10.1097/ICO.0000000000002893